Molecular cloning and functional identification of a new K+ channel blocker, LmKTx10, from the scorpion Lychas mucronatus

Peptides

Volumn 30, Issue 4, 2009, Pages 675-680

  Liu, Jun ^a   Ma, Yibao ^a   Yin, Shijin ^a,b   Zhao, Ruiming ^a   Fan, Shaozhong ^a   Hu, Youtian ^a   Wu, Yingliang ^a   Cao, Zhijian ^a   Li, Wenxin ^a  

^a WUHAN UNIVERSITY   (China)

^b SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

KTx; Kv1.3; LmKTx10; Lychas mucronatus

Indexed keywords

AMINO ACID; NEUROPEPTIDE; NEUROPEPTIDE KTX10; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; POTASSIUM CHANNEL KV1.3; RECOMBINANT PROTEIN; SCORPION VENOM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA LIBRARY; ELECTROPHYSIOLOGY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IC 50; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SCORPION; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; DNA PRIMERS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; POTASSIUM CHANNELS; RECOMBINANT PROTEINS; SCORPION VENOMS; SCORPIONS; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

LYCHAS MUCRONATUS; SCORPIONES;

EID: 62749102528     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.11.015     Document Type: Article

References (30)

1. Beeton C., Pennington M.W., Wulff H., Singh S., Nugent D., Crossley G., et al. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol 67 (2005) 1369-1381
2. + channels and inhibits T lymphocyte proliferation. J Biol Chem 283 (2008) 988-997
3. Beeton C., Wulff H., Standifer N.E., Azam P., Mullen K.M., Pennington M.W., et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci USA 103 (2006) 17414-17419
4. Bendtsen J.D., Nielsen H., von Heijne G., and Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340 (2004) 783-795
5. + current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells?. Cancer Res 58 (1998) 815-822
6. + channels. Ann N Y Acad Sci 868 (1999) 233-285
7. Dehesa-Davila M., and Possani L.D. Scorpionism and serotherapy in Mexico. Toxicon 32 (1994) 1015-1018
8. Froy O., Sagiv T., Poreh M., Urbach D., Zilberberg N., and Gurevitz M. Dynamic diversification from a putative common ancestor of scorpion toxins affecting sodium, potassium, and chloride channels. J Mol Evol 48 (1999) 187-196
9. + channels as targets for specific immunomodulation. Trends Pharmacol Sci 25 (2004) 280-289
10. Han S., Yi H., Yin S.J., Chen Z.Y., Liu H., Cao Z.J., et al. Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease. J Biol Chem 283 (2008) 19058-19065
11. Holaday Jr. S.K., Martin B.M., Fletcher Jr. P.L., and Krishna N.R. NMR solution structure of butantoxin. Arch Biochem Biophys 379 (2000) 18-27
12. Kalman K., Pennington M.W., Lanigan M.D., Nguyen A., Rauer H., Mahnir V., et al. ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. J Biol Chem 273 (1998) 32697-32707
13. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., et al. Clustal W and Clustal X version 2.0. Bioinformatics (Oxford, England) 23 (2007) 2947-2948
14. + channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin. Proc Natl Acad Sci USA 89 (1992) 10094-10098
15. Mouhat S., Teodorescu G., Homerick D., Visan V., Wulff H., Wu Y., et al. Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain. Mol Pharmacol 69 (2006) 354-362
16. + channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom. Biochem J 385 (2005) 95-104
17. + channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. Curr Pharm Des 12 (2006) 2199-2220
18. Possani L.D., Merino E., Corona M., Bolivar F., and Becerril B. Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie 82 (2000) 861-868
19. Regaya I., Beeton C., Ferrat G., Andreotti N., Darbon H., De Waard M., et al. Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins. J Biol Chem 279 (2004) 55690-55696
20. + channels and scorpion toxins. Trends Pharmacol Sci 24 (2003) 222-227
21. +-channels. Toxicon 43 (2004) 865-875
22. Schwede T., Kopp J., Guex N., and Peitsch M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31 (2003) 3381-3385
23. Shijin Y., Hong Y., Yibao M., Zongyun C., Han S., Yingliang W., et al. Characterization of a new Kv1.3 channel-specific blocker, J123, from the scorpion Buthus martensii Karsch. Peptides 29 (2008) 1514-1520
24. + channels. Biochem J 388 (2005) 455-464
25. Srinivasan K.N., Gopalakrishnakone P., Tan P.T., Chew K.C., Cheng B., Kini R.M., et al. SCORPION, a molecular database of scorpion toxins. Toxicon 40 (2002) 23-31
26. +-channel blocking peptides. Rev Physiol Biochem Pharmacol 140 (2000) 135-185
27. Tytgat J., Chandy K.G., Garcia M.L., Gutman G.A., Martin-Eauclaire M.F., van der Walt J.J., et al. A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol Sci 20 (1999) 444-447
28. + channel toxin (LmKTx8) derived from scorpion Lychas mucronatus. Peptides 28 (2007) 2306-2312
29. + channel modulators for the treatment of neurological disorders and autoimmune diseases. Chem Rev 108 (2008) 1744-1773
30. Zeng X.C., Luo F., and Li W.X. Molecular dissection of venom from Chinese scorpion Mesobuthus martensii: identification and characterization of four novel disulfide-bridged venom peptides. Peptides 27 (2006) 1745-1754